Reumuth Mary
Related Filers (1)
Ownership (19)
4
Friday, 1/5/2024
KALA BIO, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/23/2023
Kala Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/2/2023
Kala Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 3/15/2023
Kala Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/6/2023
Kala Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 10/28/2022
Kala Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/29/2022
Kala Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 1/5/2022
Kala Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 10/28/2021
Kala Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/29/2021
Kala Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 1/5/2021
Kala Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/28/2020
Kala Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Monday, 6/29/2020
Kala Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/11/2020
Kala Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/3/2020
Kala Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 1/4/2019
Kala Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 2/9/2018
Kala Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 7/21/2017
Kala Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
3
Wednesday, 7/19/2017
Kala Pharmaceuticals, Inc.: Initial statement of beneficial ownership of securities